α-Synuclein Is Degraded by Both Autophagy and the Proteasome
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Parkinson's disease (PD) is characterized by the loss of dopaminergic neurons in the substantia nigra and the formation of aggregates (Lewy bodies) in neurons. alpha-Synuclein is the major protein in Lewy bodies and rare mutations in alpha-synuclein cause early-onset PD. Consequently, alpha-synuclein is implicated in the pathogenesis of PD. Here, we have investigated the degradation pathways of alpha-synuclein, using a stable inducible PC12 cell model, where the expression of exogenous human wild-type, A30P, or A53T alpha-synuclein can be switched on and off. We have used a panel of inhibitors/stimulators of autophagy and proteasome function and followed alpha-synuclein degradation in these cells. We found that not only is alpha-synuclein degraded by the proteasome, but it is also degraded by autophagy. A role for autophagy was further supported by the presence of alpha-synuclein in organelles with the ultrastructural features of autophagic vesicles. Since rapamycin, a stimulator of autophagy, increased clearance of alpha-synuclein, it merits consideration as a potential therapeutic for Parkinsons disease, as it is designed for chronic use in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, mutant forms of synuclein and oligomers are dependent on the autophagy–lysosome pathway for their clearance4–6.”
From Loss of autophagy in dopaminergic neurons causes Lewy pathology and motor dysfunction in aged mice (2018) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous studies suggest that α-synuclein is degraded by macroautophagy, chaperone-mediated autophagy, and the proteasome20–23.”
From Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration (2020) · cites this paper as [23]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Macroautophagy is a key pathway for the clearance of aggregate-prone cytosolic proteins.”
From Lithium induces autophagy by inhibiting inositol monophosphatase (2005) · cites this paper as Webb et al., 2003
In the citing paper
“Early evidence suggested roles for CMA and macroautophagy in degrading SNCA/α‐synuclein (Webb et al, 2003; Cuervo et al, 2004).”
From Autophagy in major human diseases (2021) · cites this paper as Webb et al, 2003
In the citing paper
“We previously showed that EGFP-HDQ74 is cleared by autophagy.”
From Lithium induces autophagy by inhibiting inositol monophosphatase (2005) · cites this paper as Webb et al., 2003
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Greene, L. A., & Tischler, A. S. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.7.2424 · Cited by 5,553
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
A Drosophila model of Parkinson's disease
Feany, M. B., & Bender, W. W. (2000) · Nature · doi:10.1038/35006074 · Cited by 2,118
Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,765
Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System
Abeliovich, A., Schmitz, Y., Fariñas, I., Choi-Lundberg, D., Ho, W.-H., Castillo, P. E., Shinsky, N., Verdugo, J. M. G., Armanini, M., Ryan, A., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)80886-7 · Cited by 1,722
The ubiquitin pathway in Parkinson's disease
Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M. J., Jonnalagada, S., Chernova, T., et al. (1998) · Nature · doi:10.1038/26652 · Cited by 1,571
Conway, K. A., Harper, J. D., & Lansbury, P. T. (1998) · Nature Medicine · doi:10.1038/3311 · Cited by 1,499
Research works printed but not linked: 2
- Furlong, R. A., Narain, Y., Rankin, J., Wyttenbach, A., and Rubinsztein, D. C. (2000) Biochem. J. 346, 577-581 · DOI · Paper page
- Biederbick, A., Kern, H. F., and Elsasser, H. P. (1995) Eur. J. Cell Biol. 66, 3-14
Cited by
Items 601–700 of 1,001
Apelin/APJ system: A novel promising target for neurodegenerative diseases
Luo, H., Han, L., & Xu, J. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29001 · Cited by 63
Long, T., Wu, Q., Wei, J., Tang, Y., He, Y.-N., He, C.-L., Chen, X., Yu, L., Yu, C., Law, B. Y. K., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3723567 · Cited by 63
“For example, rapamycin is able to reduce α -synuclein accumulation and inhibit α -synu- clein-induced neurodegeneration in wild-type, A30P, or A53T α -synuclein-expressing PC-12 cells [39] and in α - synuclein-overexpressing mice [40] and rats [41], respectively.”
Arotcarena, M., Soria, F. N., Cunha, A., Doudnikoff, E., Prévot, G., Daniel, J., Blanchard‐Desce, M., Barthélémy, P., Bezard, E., Crauste‐Manciet, S., et al. (2022) · Aging Cell · doi:10.1111/acel.13584 · Cited by 58
“While α- syn can be cleared by UPS, the main pathway for its degradation appears to be mediated by the lysosome (Webb et al., 2003).”
BackgroundBiochemical and Molecular Pathways in Neurodegenerative Diseases: An Integrated View
Sanghai, N., & Tranmer, G. K. (2023) · Cells · doi:10.3390/cells12182318 · Cited by 62
“Autophagy is the regulator of misfolded aggregate-prone defective and toxic proteins that cause NDDs; for instance, mutant α -synuclein in PD [143], mutant TDP-43 in ALS [144], and A β in AD [145].”
Genetic analysis of the ATG7 gene promoter in sporadic Parkinson's disease
Chen, D., Pang, S., Feng, X., Huang, W., Hawley, R. G., & Yan, B. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2012.12.039 · Cited by 64
Clinically Precedented Protein Kinases: Rationale for Their Use in Neurodegenerative Disease
Benn, C., & Dawson, L. A. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00242 · Cited by 61
Autophagy regulation by acetylation—implications for neurodegenerative diseases
Son, S. M., Park, S. J., Fernandez-Estévez, M., & Rubinsztein, D. C. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00556-4 · Cited by 59
Self-citationRecent progress in the role of autophagy in neurological diseases
Meng, T., Lin, S., Zhuang, H., Huang, H., He, Z., Hu, Y., Gong, Q., & Feng, D. (2019) · Cell Stress · doi:10.15698/cst2019.05.186 · Cited by 58
“The pathogenic role of autophagy in PD was revealed by increasing levels of αsynuclein when lysosomes are inhibited, and misfolded αsynuclein oligomers can be removed by different catabolic pathways including macroautophagy and chaperonemediated autophagy (CMA) with different pathological situations, while α-synuclein…”
BackgroundSelective Autophagy by Close Encounters of the Ubiquitin Kind
Vainshtein, A., & Grumati, P. (2020) · Cells · doi:10.3390/cells9112349 · Cited by 63
“The usual aggregate prone suspects, including amyloid-β [82], huntingtin [83,84], and alpha synuclein [85], can all be degraded through this process.”
BackgroundLysosomal Ion Channels: What Are They Good For and Are They Druggable Targets?
Riederer, E. A., Cang, C., & Ren, D. (2022) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-051921-013755 · Cited by 61
Dyneins, Autophagy, Aggregation and Neurodegeneration
Rubinsztein, D. C., Ravikumar, B., Acevedo-Arozena, A., Imarisio, S., O’Kane, C. J., & Brown, S. D. M. (2005) · Autophagy · doi:10.4161/auto.1.3.2050 · Cited by 56
Self-citationProtein Transmission, Seeding and Degradation: Key Steps for α-Synuclein Prion-Like Propagation
Oueslati, A., Ximerakis, M., & Vekrellis, K. (2014) · Experimental Neurobiology · doi:10.5607/en.2014.23.4.324 · Cited by 73
“Although the exact mechanisms are still unclear, overall, it has been demonstrated that intracellular α-syn monomers and aggregates are predominantly degraded by the ubiquitin-proteasome system (UPS) [83-86] and the autophagy-lysosome pathway [85, 8789], including chaperone-mediated autophagy (CMA) [90, 91].”
BackgroundThe emerging role of autophagic-lysosomal dysfunction in Gaucher disease and Parkinson's disease
Kinghorn, K. J., Asghari, A., & Castillo-Quan, J. I. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.202934 · Cited by 61
Alpha-synuclein, Proteotoxicity and Parkinson's Disease: Search for Neuroprotective Therapy
Ganguly, U., Chakrabarti, S. S., Kaur, U., Mukherjee, A., & Chakrabarti, S. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666171129100944 · Cited by 61
Banerjee, P., Mehta, A. R., Nirujogi, R. S., Cooper, J., James, O. G., Nanda, J., Longden, J., Burr, K., McDade, K., Salzinger, A., et al. (2023) · Science Advances · doi:10.1126/sciadv.abq0651 · Cited by 54
“This includes recent findings that show that LC3-associated phagocytosis (LAP) in myeloid cells is an efficient intracellular eliminator of engulfed extracellular cargo, including misfolded proteins, (56, 57).”
BackgroundIdentification of autophagy as a longevity-assurance mechanism in the aging model Podospora anserina
Knuppertz, L., Hamann, A., Pampaloni, F., Stelzer, E., & Osiewacz, H. D. (2014) · Autophagy · doi:10.4161/auto.28148 · Cited by 55
“While macroautophagy and the ubiquitinproteasome system were formerly regarded as 2 separate cellular pathways with distinct functions, it is now clear that a number of proteins can be degraded by both autophagy and the proteasome.(76-79) Recent work suggests that the 2 systems “communicate” with each other under cert…”
BackgroundPP2A blockade inhibits autophagy and causes intraneuronal accumulation of ubiquitinated proteins
Magnaudeix, A., Wilson, C. M., Page, G., Bauvy, C., Codogno, P., Lévêque, P., Labrousse, F., Delage-Corre, M., Yardin, C., & Terro, F. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.06.026 · Cited by 61
“(Berger et al., 2006; Midorikawa et al., 2010; Moimoto et al., 2007; Ravikumar et al., 2004; Rideout et al., 004; Sarkar et al., 2009; Webb et al., 2003).”
Sadasivan, S., Zhang, Z., Larner, S. F., Liu, M. C., Zheng, W., Kobeissy, F. H., Hayes, R. L., & Wang, K. K. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-21 · Cited by 56
“Autophagy induction occurs in the central nervous system under conditions of stress/starvation or protein aggregating neurodegenerative diseases [5,28-30].”
BackgroundYan, J., Yuan, Y., Gao, Y., Huang, J., Ma, K., Gao, Y., Zhang, W., Guo, X., & Chen, N. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8738-1 · Cited by 58
Li, X., Chen, X., Zhao, K., Bai, L.-M., Zhang, H., & Zhou, X.-P. (2012) · International Journal of Neuroscience · doi:10.3109/00207454.2012.729234 · Cited by 57
“The autophagy-related LC3 protein, an autophagosome marker [19, 20], has previously been detected in dopaminergic neurons of the substantia nigra in mouse models of PD [21].”
BackgroundInteraction between Neuromelanin and Alpha-Synuclein in Parkinson’s Disease
Xu, S., & Chan, P. (2015) · Biomolecules · doi:10.3390/biom5021122 · Cited by 60
““autophagic stress” [144] and thereby influence the degradation of -syn [145].”
BackgroundHu, Q., Ren, X., Liu, Y., Li, Z., Zhang, L., Chen, X., He, C., & Chen, J. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.05.040 · Cited by 59
Zeng, J., Martin, A., Han, X., Shirihai, O. S., & Grinstaff, M. W. (2019) · Industrial & Engineering Chemistry Research · doi:10.1021/acs.iecr.9b02003 · Cited by 53
Dysregulated Interorganellar Crosstalk of Mitochondria in the Pathogenesis of Parkinson’s Disease
Sironi, L., Restelli, L. M., Tolnay, M., Neutzner, A., & Frank, S. (2020) · Cells · doi:10.3390/cells9010233 · Cited by 57
Clearance of Mutant Aggregate-Prone Proteins by Autophagy
Ravikumar, B., Sarkar, S., & Rubinsztein, D. C. (2008) · Methods in Molecular Biology™ · doi:10.1007/978-1-59745-157-4_13 · Cited by 53
Self-citationKuo, G., Kumbhar, R., Blair, W., Dawson, V. L., Dawson, T. M., & Mao, X. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00797-1 · Cited by 62
Enhanced Lysosomal Pathology Caused by β-Synuclein Mutants Linked to Dementia with Lewy Bodies
Wei, J., Fujita, M., Nakai, M., Waragai, M., Watabe, K., Akatsu, H., Rockenstein, E. M., Masliah, E., & Hashimoto, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703711200 · Cited by 55
Alpha-synuclein-based models of Parkinson's disease
Dehay, B., & Fernagut, P. (2016) · Revue Neurologique · doi:10.1016/j.neurol.2016.04.003 · Cited by 60
Jahrling, J., & Laberge, R.-M. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150610125856 · Cited by 53
“Additionally, alpha synuclein, a primary component of Lewy body plaques observed in PD, is known to be degraded in part through autophagy, and cell culture experiments using mutated alpha synuclein demonstrated increased aggregation when autophagy was inhibited [74], further suggesting that enhanced autophagy may prov…”
BackgroundKoller, E. J., Brooks, M. M. T., Golde, T. E., Giasson, B. I., & Chakrabarty, P. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0142-z · Cited by 54
“Both the autophagy-lysosomal pathway and the ubiquitin proteasome system have been shown to play crucial roles in αSyn clearance [45].”
Induction of macroautophagy by overexpression of the Parkinson's disease‐associated GPR37 receptor
Marazziti, D., Pietro, C. D., Golini, E., Mandillo, S., Matteoni, R., & Tocchini‐Valentini, G. P. (2009) · The FASEB Journal · doi:10.1096/fj.08-121210 · Cited by 62
“Several studies with tissue culture and transgenic animal models have shown that the autophagic proteolytic pathway is crucially involved in regulating the clearance of abnormally accumulated proteins, such as huntingtin, expanded polyalanine repeats, and mutant -synuclein, whose intracellular aggregation is associate…”
BackgroundPotentiation of methamphetamine neurotoxicity by intrastriatal lipopolysaccharide administration
Jung, B.-D., Shin, E., Nguyen, X.-K. T., Jin, C., Bach, J., Park, S. J., Nah, S.-Y., Wie, M., Bing, G., & Kim, H. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.10.005 · Cited by 55
Novel One-step Immunoassays to Quantify α-Synuclein
Bidinosti, M., Shimshek, D. R., Mollenhauer, B., Marcellin, D., Schweizer, T., Lotz, G. P., Schlossmacher, M. G., & Weiss, A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.379792 · Cited by 59
“As anticipated from earlier work (11, 35), treatment with rapamycin as an on-plate control effected -synuclein reduction.”
ResultTargeted Suppression of Chaperone-Mediated Autophagy by miR-320a Promotes α-Synuclein Aggregation
Li, G., Yang, H., Zhu, D., Huang, H., Liu, G., & Lun, P. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150915845 · Cited by 60
Wei, C., Chang, C., & Liao, V. H. (2017) · Phytomedicine · doi:10.1016/j.phymed.2017.09.002 · Cited by 56
Deshayes, N., Arkan, S., & Hansen, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184495 · Cited by 57
Neurons and Glia Interplay in α-Synucleinopathies
Mavroeidi, P., & Xilouri, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094994 · Cited by 62
Activated microglia facilitate the transmission of α-synuclein in Parkinson's disease
Zheng, T., & Zhang, Z. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105094 · Cited by 61
mTOR Modulates Methamphetamine‐Induced Toxicity through Cell Clearing Systems
Lazzeri, G., Biagioni, F., Fulceri, F., Busceti, C. L., Scavuzzo, M. C., Ippolito, C., Salvetti, A., Lenzi, P., & Fornai, F. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6124745 · Cited by 53
Regulation of α-synuclein homeostasis and inflammasome activation by microglial autophagy
Choi, I., Heaton, G. R., Lee, Y.-K., & Yue, Z. (2022) · Science Advances · doi:10.1126/sciadv.abn1298 · Cited by 58
“Pharmacological experiments using proteasome inhibitors, such as epoxomicin, clasto-lactacystin -lactone, and MG132, were shown to block the degradation of -synuclein in animals and differentiated neuronal cell lines (63, 64).”
MethodLysosomal dysfunction in α-synuclein pathology: molecular mechanisms and therapeutic strategies
Dai, L., Liu, M., Ke, W., Chen, L., Fang, X., & Zhang, Z. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05419-5 · Cited by 61
“Blocking the ALP with bafilomycin A1 results in the accumulation of α-syn aggregates in primary cortical neurons and nonneuronal cells [96, 97].”
BackgroundInterplay between the ubiquitin-proteasome system and autophagy in proteinopathies.
Zheng, Q., Li, J., & Wang, X. (2009) · Europe PMC (PubMed Central) · Cited by 70
Tung, Y.-T., Hsu, W., Lee, H., Huang, W., & Liao, Y. (2010) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-010-9507-y · Cited by 58
“could play a vital role in the pathogenesis of HD and other neurodegenerative diseases caused by abnormal protein aggregates, such as tauopathies and a-synucleinopathies (Hamano et al. 2008; Webb et al. 2003).”
BackgroundWang, P., Li, B., Zhou, L., Fei, E., & Wang, G. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.06.008 · Cited by 54
Autophagy and Its Comprehensive Impact on ALS
Song, C.-Y., Guo, J.-F., Liu, Y., & Tang, B.-S. (2012) · International Journal of Neuroscience · doi:10.3109/00207454.2012.714430 · Cited by 51
“Those diseases include ALS [30, 33, 34], Alzheimer disease (AD) [35], Parkinson disease (PD) [36], Huntington disease (HD) [37], and many others.”
BackgroundLiu, X., Hebron, M. L., Mulki, S., Wang, C., Lekah, E., Ferrante, D., Shi, W., Kurd-Misto, B. T., & Moussa, C. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190635 · Cited by 59
Autophagy-Lysosomal Pathway as Potential Therapeutic Target in Parkinson’s Disease
Bonam, S. R., Tranchant, C., & Muller, S. (2021) · Cells · doi:10.3390/cells10123547 · Cited by 57
Pukaß, K., & Richter‐Landsberg, C. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00163 · Cited by 54
Papiani, G., Ruggiano, A., Fossati, M., Raimondi, A., Bertoni, G., Francolini, M., Benfante, R., Navone, F., & Borgese, N. (2012) · Journal of Cell Science · doi:10.1242/jcs.102137 · Cited by 54
“A number of IBs are known to be cleared by autophagocytosis, including those formed by polyQ or polyA expanded proteins (Iwata et al., 2005; Ravikumar et al., 2002), and by synuclein (Olzmann and Chin, 2008; Webb et al., 2003).”
BackgroundFibrillar α-synuclein toxicity depends on functional lysosomes
Guiney, S. J., Adlard, P. A., Lei, P., Mawal, C., Bush, A. I., Finkelstein, D. I., & Ayton, S. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013428 · Cited by 56
“-In mitotic and differentiated PC12 cells induced to over-express WT or A53T α-synuclein, bafilomycin A1 decreased clearance of A53T but not WT α-synuclein (75).”
BackgroundInfluentialBains, M., Florez-McClure, M. L., & Heidenreich, K. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.011791 · Cited by 52
HIV-1 Vpr protein impairs lysosome clearance causing SNCA/alpha-synuclein accumulation in neurons
Santerre, M., Arjona, S. P., Allen, C. N. S., Callen, S. E., Buch, S. J., & Sawaya, B. E. (2021) · Autophagy · doi:10.1080/15548627.2021.1915641 · Cited by 51
“SNCA and other toxic proteins are normally removed from the cells through the cellular housekeeping mechanism known as autophagy [11].”
BackgroundRobust LC3B lipidation analysis by precisely adjusting autophagic flux
Liebl, M. P., Meister, S. C., Frey, L., Hendrich, K., Klemmer, A., Wohlfart, B., Untucht, C., Nuber, J., Pohl, C., & Lakics, V. (2022) · Scientific Reports · doi:10.1038/s41598-021-03875-8 · Cited by 53
Zhang, J., Zhang, Y., Li, J., Xing, S., Li, C., Li, Y., Dang, C., Fan, Y., Yu, J., Pei, Z., et al. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07496.x · Cited by 52
Prion degradation pathways: Potential for therapeutic intervention
Goold, R., McKinnon, C., & Tabrizi, S. J. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2014.12.009 · Cited by 58
“, 2004),α-Synuclein (Webb et al., 2003), APP (Spilman et al.”
Changes in autophagy proteins in a rat model of controlled cortical impact induced brain injury
Sadasivan, S., Dunn, W. A., Hayes, R. L., & Wang, K. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.05.031 · Cited by 53
Lamore, S. D., & Wondrak, G. T. (2012) · Photochemical & Photobiological Sciences · doi:10.1039/c1pp05131h · Cited by 51
Activating Autophagy as a Therapeutic Strategy for Parkinson’s Disease
Fowler, A. J., & Moussa, C. (2018) · CNS Drugs · doi:10.1007/s40263-018-0497-5 · Cited by 54
Protein and Mitochondria Quality Control Mechanisms and Cardiac Aging
Ghosh, R., Vinod, V., Symons, J. D., & Boudina, S. (2020) · Cells · doi:10.3390/cells9040933 · Cited by 53
Induction of C/EBPβ and GADD153 expression by dopamine in human neuroblastoma cells
Gómez-Santos, C., Barrachina, M., Giménez‐Xavier, P., Dalfó, E., Ferrer, I., & Ambrosio, S. (2004) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2004.11.008 · Cited by 51
Duka, T., & Sidhu, A. (2006) · Neurotoxicity Research · doi:10.1007/bf03033329 · Cited by 57
“Another potential pathway for clearance of aggregated α-Syn, involves autophagy (Klionsky and Emr, 2000; Webb et al., 2003), but the effect of MPTP/MPP+ on the autophagy pathway is unknown.”
BackgroundPanda, P. K., Fahrner, A., Vats, S., Seranova, E., Sharma, V., Chipara, M., Desai, P., Torresi, J., Rosenstock, T., Kumar, D., et al. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00038 · Cited by 50
“A potential role of simvastatin, which has been reported to induce autophagy by inhibiting the Rac1-mTOR pathway (Wei et al., 2013), has been suggested in improving the physiological function of skeletal muscle in DMD transgenic mice (Whitehead et al., 2015).”
BackgroundInhibition of lysosomal functions reduces proteasomal activity
Qiao, L., & Zhang, J. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.03.085 · Cited by 50
Pantazopoulou, M., Brembati, V., Kanellidi, A., Bousset, L., Melki, R., & Stefanis, L. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15174 · Cited by 52
“…WT, but not mutant α-Syn is mainly degraded by the selective process of chaperone-mediated autophagy; all forms can be cleared by macroautophagy (Alvarez-Erviti et al., 2010; Cuervo, Stefanis, Fredenburg, Lansbury, & Sulzer, 2004; Vogiatzi, Xilouri, Vekrellis, & Stefanis, 2008; Webb et al., 2003).”
BackgroundRoselló, A., Warnes, G., & Meier, U. (2012) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04544.x · Cited by 52
Measurement of Autophagic Activity in Mammalian Cells
Menzies, F. M., Moreau, K., Puri, C., Renna, M., & Rubinsztein, D. C. (2012) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb1516s54 · Cited by 51
Self-citationLatge, C., Cabral, K. M. S., de Oliveira, G. A. P., Raymundo, D. P., Freitas, J. A., Johanson, L., Romão, L. F., Palhano, F. L., Herrmann, T., Almeida, M. S., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.662254 · Cited by 49
“The cellular clearance of -synuclein is performed by the ubiquitin-proteasome system and chaperone-mediated autophagy (64), and interventions that stimulate chaperone-mediated autophagy can prevent -synucleinopathy (65–67).”
BackgroundImportant Role of Autophagy in Regulation of Metabolic Processes in Health, Disease and Aging
Papáčková, Z., & Cahová, M. (2014) · Physiological Research · doi:10.33549/physiolres.932684 · Cited by 51
Martínez‐Vicente, M., & Vila, M. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.03.005 · Cited by 56
Triptolide Promotes the Clearance of α-Synuclein by Enhancing Autophagy in Neuronal Cells
Hu, G., Gong, X., Wang, L., Liu, M., Liu, Y., Fu, X., Wang, W., Zhang, T., & Wang, X. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9808-3 · Cited by 52
Sanyal, A., Novis, H. S., Gasser, E., Lin, S. C., & LaVoie, M. J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00442 · Cited by 53
“…classic neuronal Lewy body formation (Alegre-Abarrategui et al., 2008; Vitte et al., 2010; Yacoubian et al., 2010). αSyn can be degraded both by the proteasome and the lysosome and its deposition in PD could conceivably arise from deficits in either pathway (Webb et al., 2003; Yan et al., 2018).”
BackgroundPukaß, K., Goldbaum, O., & Richter‐Landsberg, C. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13256 · Cited by 49
Proteasomal and autophagic degradative activities in spinal and bulbar muscular atrophy
Rusmini, P., Bolzoni, E., Crippa, V., Onesto, E., Sau, D., Galbiati, M., Piccolella, M., & Poletti, A. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.06.016 · Cited by 48
Role of autophagy and its significance in cellular homeostasis
Awan, M. U. F., & Deng, Y. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-014-5721-8 · Cited by 50
“There function is linked, thus if one inhibits, the other will upregulate (Webb et al. 2003).”
The phagocytic capacity of neurones
Bowen, S., Ateh, D. D., Deinhardt, K., Bird, M. M., Price, K. M., Baker, C. S., Robson, J. C., Swash, M., Shamsuddin, W., Kawar, S., et al. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05554.x · Cited by 47
“…received much attention in the context of protein conformational disorders and protein aggregation (Johnston et al., 1998; Ravikumar et al., 2002; Webb et al., 2003) but this may not explain all of the structural cellular changes seen in these pathologies or provide a better understanding of…”
BackgroundThe effects of the novel A53E alpha-synuclein mutation on its oligomerization and aggregation
Lázaro, D. F., Dias, M. C., Čarija, A., Navarro, S., Madaleno, C. S., Tenreiro, S., Ventura, S., & Outeiro, T. F. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0402-8 · Cited by 52
“In cell models, it has been shown that aSyn accumulation can affect the activity of the UPS system [61].”
Ahlemeyer, B., Halupczok, S., Rodenberg-Frank, E., Valerius, K.-P., & Baumgart-Vogt, E. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170923 · Cited by 45
The unlikely partnership between LRRK 2 and α‐synuclein in Parkinson's disease
Cresto, N., Gardier, C., Gubinelli, F., Gaillard, M., Liot, G., West Andrew, B., & Brouillet, E. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14182 · Cited by 54
Autophagy Modulators and Neuroinflammation
Cho, K. S., Lee, J. H., Cho, J., Cha, G., & Song, G. J. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666181031144605 · Cited by 52
McCracken, A. A., & Brodsky, J. L. (2006) · Springer eBooks · doi:10.1007/3-540-28007-3_2 · Cited by 57
Riedel, M. J., Goldbaum, O., & Richter‐Landsberg, C. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9190-y · Cited by 50
“Degradation of αsynuclein occurs by both the proteasome and lysosomal pathways (Tofaris et al. 2001; Webb et al. 2003; Lee et al. 2004a, b; Cuervo et al. 2004), and the co-chaperone CHIP (carboxyl terminus of Hsp70-interacting protein) has been suggested to be involved as a molecular switch between…”
BackgroundPukaß, K., & Richter‐Landsberg, C. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0154-x · Cited by 52
“The absence of distinct aggresome-like structures in oligodendroglial cells may be indicative of efficient degradation systems which, as corroborated in the present study in the case of soluble α-Syn, involves the ubiquitin proteasomal system and for larger aggregates may require the autophagosomal pathway (Lee et al.…”
BackgroundInfluentialCasadei, N., Pöhler, A.-M., Tomás‐Zapico, C., Torres-Peraza, J. F., Schwedhelm, I., Witz, A., Zamolo, I., de Heer, R. C., Spruijt, B. M., Noldus, L. P. J. J., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt467 · Cited by 52
“In mammals, the ubiquitin–proteasome system (UPS) (26) and the autophagy–lysosome pathway (ALP) are the two major mechanisms involved in the degradation of a-syn (27).”
A novel and functional variant within the ATG5 gene promoter in sporadic Parkinson's disease
Chen, D., Zhu, C., Wang, X., Feng, X., Pang, S., Huang, W., Hawley, R. G., & Yan, B. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.01.044 · Cited by 50
Protein clearance strategies for disease intervention
Hommen, F., Bilican, S., & Vílchez, D. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02431-y · Cited by 51
Autophagy‐associated non‐coding RNAs: Unraveling their impact on Parkinson's disease pathogenesis
Hussain, M. S., Moglad, E. H. O., Afzal, M., Sharma, S., Gupta, G., Sivaprasad, G. V., Deorari, M., Almalki, W. H., Kazmi, I. A., Alzarea, S. I., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14763 · Cited by 52
Alpha-Synuclein and Microglia in Parkinson’s Disease: From Pathogenesis to Therapeutic Prospects
Eo, H., Kim, S., Jung, U. J., & Kim, S. R. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13237243 · Cited by 54
Site-Specific Differences in Proteasome-Dependent Degradation of Monoubiquitinated α-Synuclein
Abeywardana, T., Lin, Y., Rott, R., Engelender, S., & Pratt, M. R. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.09.009 · Cited by 49
“…have demonstrated that α-synuclein can be degraded by proteasomal, lysosomal, and autophagic pathways (Paxinou et al., 2001; Rott et al., 2008; 2011; Webb, 2003), and we have shown that the balance between these different mechanisms is controlled by the posttranslational modification of…”
BackgroundConsequences of the DYT1 mutation on torsinA oligomerization and degradation
Gordon, K. L., & Gonzalez-Alegre, P. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.09.028 · Cited by 51
“Treatment with 3MA was well tolerated for 48h whereas, in contrast to previous reports (Webb et al., 2003), proteasome inhibition prolonged more than 24h induced significant cell death (not shown).”
BackgroundResultUbiquitin proteasome system in Parkinson's disease: A keeper or a witness?
Martins-Branco, D., Esteves, A. R., Santos, D., Arduino, D. M., Swerdlow, R. H., Oliveira, C. R., Januario, C., & Cardoso, S. M. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.08.008 · Cited by 44
Iron Dysregulation in Parkinson’s Disease: Focused on the Autophagy–Lysosome Pathway
Chen, L., Huang, Y., Cui, J., Song, N., & Xie, J. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00390 · Cited by 50
Cai, C.-Z., Zhou, H., Yuan, N.-N., Wu, M.-Y., Lee, S. M., Ren, J., Su, H., Lu, J., Chen, X., Li, M., et al. (2019) · Phytomedicine · doi:10.1016/j.phymed.2019.152842 · Cited by 48
Dysregulated autophagy as a new aspect of the molecular pathogenesis of Krabbe disease
Grosso, A. D., Angella, L., Tonazzini, I., Moscardini, A., Giordano, N., Caleo, M., Rocchiccioli, S., & Cecchini, M. G. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.05.011 · Cited by 49
Li, Y., Zhu, Z., Chen, J., Zhang, M., Yang, Y., & Huang, P. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00161 · Cited by 48
Impact of Chaperone-Mediated Autophagy in Brain Aging: Neurodegenerative Diseases and Glioblastoma
Auzmendi-Iriarte, J., & Matheu, A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.630743 · Cited by 50
Fredriksen, K., Aivazidis, S., Sharma, K., Burbidge, K. J., Pitcairn, C., Zunke, F., Gelyana, E., & Mazzulli, J. R. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2108489118 · Cited by 49
Crosstalk between the proteasome system and autophagy in the clearance of α-synuclein
Yang, F. W., Yang, Y., Mao, C., Liu, L., Zheng, H.-F., Hu, L., & Liu, C.-F. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.29 · Cited by 49
Reduction of DHHC5-mediated beclin 1 S-palmitoylation underlies autophagy decline in aging
Guo, R., Liu, J., Min, X., Zeng, W., Shan, B., Zhang, M., He, Z., Zhang, Y., He, K., Yuan, J., et al. (2024) · Nature Structural & Molecular Biology · doi:10.1038/s41594-023-01163-9 · Cited by 48
“Autophagy is essential for the degradation of aggregate-prone proteins, including polyglutamine-expanded proteins, α-synuclein, β-amyloid (Aβ) and neurofibrillary tangles 32–35 .”
p 62 Deficiency Enhances α‐Synuclein Pathology in Mice
Tanji, K., Odagiri, S., Miki, Y., Maruyama, A., Nikaido, Y., Mimura, J., Mori, F., Warabi, E., Yanagawa, T., Ueno, S., et al. (2014) · Brain Pathology · doi:10.1111/bpa.12214 · Cited by 49
Impairment of autophagy: From hereditary disorder to drug intoxication
Aki, T., Funakoshi, T., Unuma, K., & Uemura, K. (2013) · Toxicology · doi:10.1016/j.tox.2013.07.001 · Cited by 51
Metadata
- Authors
- Webb, J. L., Ravikumar, B., Atkins, J., Skepper, J. N., & Rubinsztein, D. C.
- Affiliations
- Addenbrooke's Hospital (GB)
- University of Cambridge (GB)
- Corresponding author
- Rubinsztein, David C.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-07
- Volume
- 278
- Issue
- 27
- Pages
- 25009-25013
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2157535220
- Cited by
- 1,429
- References
- 37
- Citations by year
- 2026: 36 · 2025: 41 · 2024: 76 · 2023: 50 · 2022: 68 · 2021: 71 · 2020: 83 · 2019: 85 · 2018: 77 · 2017: 62 · 2016: 65 · 2015: 65 · 2014: 75 · 2013: 79 · 2012: 95
- FWCI
- 18.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6305 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Parkinson's UK
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- alpha-synuclein, Parkinson's disease, autophagy, proteasome, protein degradation, Lewy bodies, A30P mutation, A53T mutation, PC12 cells, rapamycin, autophagic vesicles, dopaminergic neurons
- MeSH terms
- Animals, Antibiotics, Antineoplastic, Autophagy, Cysteine Endopeptidases, Humans, Multienzyme Complexes, Nerve Tissue Proteins, PC12 Cells, Sirolimus, Proteasome Endopeptidase Complex, Rats, Synucleins, alpha-Synuclein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.